NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,786,839 | +8.3% | 60,623 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $2,573,297 | +174124.6% | 61,022 | +7.8% | 0.00% | 0.0% |
| Q1 2023 | $1,477 | -17.9% | 56,620 | -6.3% | 0.00% | 0.0% |
| Q4 2022 | $1,800 | -99.8% | 60,447 | +61.4% | 0.00% | – |
| Q3 2022 | $728,000 | +29.3% | 37,452 | -9.7% | 0.00% | – |
| Q2 2022 | $563,000 | +76.5% | 41,491 | +56.4% | 0.00% | – |
| Q1 2022 | $319,000 | +2.6% | 26,526 | +68.4% | 0.00% | – |
| Q4 2021 | $311,000 | -12.4% | 15,749 | 0.0% | 0.00% | – |
| Q3 2021 | $355,000 | – | 15,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |